46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05182203 (ClinicalTrials.gov) | January 2022 | 18/12/2021 | Safety and Retention Rate of the JAK Inhibitors in Rheumatoid Arthritis: a Real-life Experience | Safety and Retention Rate of the JAK Inhibitors in Rheumatoid Arthritis: a Real-life Experience | Rheumatoid Arthritis;Drug Use | Drug: biologic/targeted therapy | Tuen Mun Hospital | NULL | Not yet recruiting | 18 Years | N/A | All | 1800 | China |